Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-16,023
Closed -$2.6M 91
2015
Q4
$2.6M Buy
+16,023
New +$2.52M 0.07% 103
2015
Q3
Sell
-24,159
Closed -$3.71M 336
2015
Q2
$3.71M Buy
24,159
+2,109
+10% +$338K 0.16% 135
2015
Q1
$3.52M Sell
22,050
-26,052
-54% -$4.1M 0.14% 141
2014
Q4
$7.66M Sell
48,102
-66,700
-58% -$10.4M 0.31% 73
2014
Q3
$16.1M Sell
114,802
-20,148
-15% -$2.63M 0.63% 34
2014
Q2
$16M Buy
+134,950
New +$15.6M 0.63% 37

Other funds holding AMGN

Whitebox Advisors's AMGN Position: Q1 2016 in Review

Whitebox Advisors sold out of Amgen (AMGN) in Q1 2016, closing a stake of 16,023 shares — an estimated $2.6M sold.

Whitebox Advisors first reported a position in AMGN in Q2 2014 and held it in 6 quarters. The position peaked at $16.1M in Q3 2014. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Whitebox Advisors reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
  • Whitebox Advisors sold 16,023 Amgen shares in Q1 2016, an estimated $2.6M.
  • Whitebox Advisors first reported a position in Amgen in Q2 2014 and held it in 6 quarters.
  • Whitebox Advisors's Amgen position peaked at $16.1M in Q3 2014.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Whitebox Advisors's 13F filing for Q1 2016, filed 3 May 2016.